Terms: = Endocrine gland cancer AND FEV, Pet-1, 54738, ENSG00000163497, PET-1, HSRNAFEV
9 results:
1. I-PET score: Combining whole body iodine and
Wijewardene A; Hoang J; Maw AM; Gild M; Tacon L; Roach P; Schembri G; Chan D; Clifton-Bligh R
Clin Endocrinol (Oxf); 2023 Mar; 98(3):436-446. PubMed ID: 35918798
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of dexmedetomidine as an adjunct to ropivacaine in bilateral dual-transversus abdominis plane blocks in patients with ovarian cancer who underwent cytoreductive surgery.
Zhang JP; Zhang N; Chen X; Zhou Y; Jiang Z; Gao C; Xie YH; Wang S; Zhang W
BMC Anesthesiol; 2022 Jan; 22(1):20. PubMed ID: 35021994
[TBL] [Abstract] [Full Text] [Related]
3. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs endocrines.
Triponez F; Sadowski SM; Pattou F; Cardot-Bauters C; Mirallié E; Le Bras M; Sebag F; Niccoli P; Deguelte S; Cadiot G; Poncet G; Lifante JC; Borson-Chazot F; Chaffanjon P; Chabre O; Menegaux F; Baudin E; Ruszniewski P; Du Boullay H; Goudet P
Ann Surg; 2018 Jul; 268(1):158-164. PubMed ID: 28263205
[TBL] [Abstract] [Full Text] [Related]
4. Specific behaviour, mood and personality traits may contribute to obesity in patients with craniopharyngioma.
Roemmler-Zehrer J; Geigenberger V; Störmann S; Ising M; Pfister H; Sievers C; Stalla GK; Schopohl J
Clin Endocrinol (Oxf); 2015 Jan; 82(1):106-14. PubMed ID: 24923438
[TBL] [Abstract] [Full Text] [Related]
5. Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.
Ubhi BK; Cheng KK; Dong J; Janowitz T; Jodrell D; Tal-Singer R; MacNee W; Lomas DA; Riley JH; Griffin JL; Connor SC
Mol Biosyst; 2012 Oct; 8(12):3125-33. PubMed ID: 23051772
[TBL] [Abstract] [Full Text] [Related]
6. Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan.
Kim WG; Ryu JS; Kim EY; Lee JH; Baek JH; Yoon JH; Hong SJ; Kim ES; Kim TY; Kim WB; Shong YK
J Clin Endocrinol Metab; 2010 Mar; 95(3):1169-73. PubMed ID: 20080852
[TBL] [Abstract] [Full Text] [Related]
7. Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis.
Duerr EM; Mizukami Y; Ng A; Xavier RJ; Kikuchi H; Deshpande V; Warshaw AL; Glickman J; Kulke MH; Chung DC
Endocr Relat Cancer; 2008 Mar; 15(1):243-56. PubMed ID: 18310291
[TBL] [Abstract] [Full Text] [Related]
8. Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer.
Cho SM; Ha HK; Byun JY; Lee JM; Kim CJ; Nam-Koong SE; Lee JM
AJR Am J Roentgenol; 2002 Aug; 179(2):391-5. PubMed ID: 12130439
[TBL] [Abstract] [Full Text] [Related]
9. [Low preoperative PaO2 in patients with ovarian and endometrial cancer].
Fukuda K; Chinzei M; Hayashida M; Suwa K; Hanaoka K; Kawashima Y
Masui; 1997 Apr; 46(4):506-10. PubMed ID: 9128022
[TBL] [Abstract] [Full Text] [Related]
